Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancer

Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancer

Abstract Background Pancreatic cancer (PC) is a malignant tumor with extremely poor prognosis, exhibiting resistance to chemotherapy and immunotherapy. Nowadays, it is ranked as the third leading cause of cancer-related mortality. Glycation is a common epigenetic modification that occurs during the...

Full description

Bibliographic Details
Main Authors:	XueAng Liu, Jian Shi, Lei Tian, Bin Xiao, Kai Zhang, Yan Zhu, YuFeng Zhang, KuiRong Jiang, Yi Zhu, Hao Yuan
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Series:	BMC Cancer
Subjects:	Pancreatic cancer Cancer glycosylation Prognostic model Bioinformatics B3GNT8
Online Access:	https://doi.org/10.1186/s12885-023-11725-1

Similar Items

Physiological relevance of protein-glycosylation to pathogenesis of diabetes
by: Kazuaki Ohtsubo, et al.
Published: (2014-05-01)

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness
by: Zhaorui Miao, et al.
Published: (2022-05-01)

Roles of Integrin α6β4 Glycosylation in Cancer
by: Yoshinobu Kariya, et al.
Published: (2017-07-01)

Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells
by: Srikanth Barkeer, et al.
Published: (2018-11-01)

High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation
by: Hsi-Chang Shih, et al.
Published: (2019-01-01)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
by: Jiacheng Huang, et al.
Published: (2021-08-01)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
by: Rui Gou, et al.
Published: (2019-09-01)

<i>N</i>-Glycosylation of LRP6 by B3GnT2 Promotes Wnt/β-Catenin Signalling
by: Ruiyao Xu, et al.
Published: (2023-03-01)

The subsidiary GntII system for gluconate metabolism in Escherichia coli: Alternative induction of the gntV gene
by: Keyla M Gómez, et al.
Published: (2011-01-01)

The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation
by: Tobias Willer, et al.
Published: (2014-10-01)

Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer
by: Yunjie Duan, et al.
Published: (2022-04-01)

β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion
by: YingHao Luo, et al.
Published: (2023-09-01)

Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma
by: Yalu Zhang, et al.
Published: (2022-01-01)

Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer
by: Xiaole Zhu, et al.
Published: (2022-09-01)

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients
by: Eva Valentina Klocker, et al.
Published: (2020-05-01)

OASL Expression in Pancreatic Cancer and Its Effect on Proliferation and Migration of Pancreatic Cancer Cells
by: ZHANG Rendan, et al.
Published: (2023-01-01)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
by: Cheng Yang, et al.
Published: (2022-03-01)

B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan
by: Jeremy L Praissman, et al.
Published: (2014-10-01)

Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma
by: Xu-Sheng Liu, et al.
Published: (2021-02-01)

Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer
by: Shihan Xiao, et al.
Published: (2022-04-01)

A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis
by: Liang Chen, et al.
Published: (2022-10-01)

Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis
by: Yizhi Wang, et al.
Published: (2024-04-01)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
by: Ioannis Vezakis, et al.
Published: (2023-08-01)

Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma
by: Lin SS, et al.
Published: (2023-10-01)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
by: Huan Zhang, et al.
Published: (2020-09-01)

Recent Advances in Mass Spectrometry-Based Glycomic and Glycoproteomic Studies of Pancreatic Diseases
by: Dylan Nicholas Tabang, et al.
Published: (2021-07-01)

The inverted U‐shaped relationship between epinephrine and pancreatic ductal adenocarcinoma patients' survival with compensation of lymphocyte
by: Bing‐Xue Li, et al.
Published: (2024-04-01)

Diagnostic and prognostic role of circRNAs in pancreatic cancer: a meta-analysis
by: Ruihua Zhao, et al.
Published: (2023-06-01)

Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication
by: Jun Hou, et al.
Published: (2021-02-01)

Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior
by: Tao Zhang, et al.
Published: (2020-06-01)

Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
by: Dimitrios Giannis, et al.
Published: (2021-03-01)

PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
by: Biao Zhang, et al.
Published: (2023-07-01)

Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma
by: Yu Ma, et al.
Published: (2024-03-01)

Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy
by: Manikandan Muthu, et al.
Published: (2020-12-01)

Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer
by: Lewei Yang, et al.
Published: (2022-04-01)

The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis
by: Lingyu Hu, et al.
Published: (2021-10-01)

IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation
by: Pei Cao, et al.
Published: (2023-02-01)

Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer
by: Xin-jie Du, et al.
Published: (2023-02-01)

The combined prognostic model of copper-dependent to predict the prognosis of pancreatic cancer
by: Xiao Guan, et al.
Published: (2022-08-01)

Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
by: Benjamin Emil Stubbe, et al.
Published: (2021-11-01)